Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels

This publication has 17 references indexed in Scilit:

• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
  Diabetes Care, 1997
• Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
  Diabetes Care, 1997
• Diabetes, Asymptomatic Hyperglycemia, and 22-Year Mortality in Black and White Men: The Chicago Heart Association Detection Project in Industry Study
  Diabetes Care, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes
  Diabetes Care, 1995
• Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)
  The American Journal of Cardiology, 1991
• A Cross‐sectional Analysis of Glucose Tolerance and Cardiovascular Disease in 67–year‐old Men
  Diabetic Medicine, 1989
• Diabetes and atherosclerosis: An epidemiologic view
  Diabetes/Metabolism Research and Reviews, 1987
• The Role of Circulating Glucose and Triglyceride Concentrations and Their Interactions with Other “Risk Factors” as Determinants of Arterial Disease in Nine Diabetic Population Samples from the WHO Multinational Study
  Diabetes Care, 1983
• Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study
  Diabetes Care, 1979